These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Lupus nephritis from the histologic point of view]. Nagasawa T Ryumachi; 1985 Nov; 25(5):372-80. PubMed ID: 3832481 [No Abstract] [Full Text] [Related]
23. Lupus nephritis; a case report. Rao NR; Reddy CR; Rao AN; Krishnamoorthy DE Indian J Med Sci; 1968 Oct; 22(10):717-9. PubMed ID: 5707052 [No Abstract] [Full Text] [Related]
24. Cimetidine-induced elevation of serum creatinine in a patient with lupus nephritis. Morley JJ; Ballou SP J Rheumatol; 1983 Jun; 10(3):520-2. PubMed ID: 6887181 [No Abstract] [Full Text] [Related]
25. [Clinico-morphological comparisons in lupous nephritis]. Tareeva IE; Potekaeva MA Klin Med (Mosk); 1968 Jul; 46(7):54-60. PubMed ID: 5715089 [No Abstract] [Full Text] [Related]
27. [Pathological findings and clinical manifestations in 27 cases of lupus nephritis]. Huang YJ Zhonghua Yi Xue Za Zhi; 1982 Oct; 62(10):586-90. PubMed ID: 6817882 [No Abstract] [Full Text] [Related]
28. [Use of heparin in the complex treatment of lupus nephritis in children]. Kartasheva VI; Popkova GK; Torik ZhN Vopr Revm; 1976; (1):35-41. PubMed ID: 982931 [No Abstract] [Full Text] [Related]
29. [Characteristics of collagen nephropathies and their treatment]. Siniachenko VV Vrach Delo; 1977 Oct; (10):96-100. PubMed ID: 602144 [No Abstract] [Full Text] [Related]
30. Studies of tubular alterations in diffuse renal disease. II. Quantitative evaluation of cellularity and length of proximal convoluted tubules in the kidney of lupus nephritis. Garcia-Caceres U; Ortega J Am J Pathol; 1967 Jun; 50(6):1009-26. PubMed ID: 4164874 [No Abstract] [Full Text] [Related]
31. Oral manifestation of systemic lupus erythematosus: lupus nephritis--report of a case. Sverzut AT; Allais M; Mazzonetto R; de Moraes M; Passeri LA; Moreira RW Gen Dent; 2008; 56(1):35-41. PubMed ID: 18254558 [TBL] [Abstract][Full Text] [Related]
34. Association of antioxidized low-density lipoprotein antibodies with vascular arterial events and renal manifestations in systemic lupus erythematosus patients: comment on the article by Frostegård et al. Bertoli AM; Fernández M; McGwin G; Vilá LM; Reveille JD; Alarcón GS; Arthritis Rheum; 2006 Jun; 54(6):2035-6. PubMed ID: 16732576 [No Abstract] [Full Text] [Related]
35. [Nephritis by lupus erythematosus. Prognostic and therapeutic considerations (apropos of 22 personal cases)]. SIGUIER F; BETOURNE C; SARRAZIN A; MIHAUD A; GODEAU P; SLAMA R Bull Mem Soc Med Hop Paris; 1960 May 13-20; 76():682-91. PubMed ID: 14446604 [No Abstract] [Full Text] [Related]
36. Vascular complications in lupus nephritis and lupus-like syndromes. Seshan SV Wien Klin Wochenschr; 2000 Aug; 112(15-16):687-91. PubMed ID: 11020958 [No Abstract] [Full Text] [Related]